Prediction of visual function from automatically quantified optical coherence tomography biomarkers in patients with geographic atrophy using machine learning.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
16 Sep 2022
Historique:
received: 22 06 2022
accepted: 29 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Geographic atrophy (GA) is a vision-threatening manifestation of age-related macular degeneration (AMD), one of the leading causes of blindness globally. Objective, rapid, reliable, and scalable quantification of GA from optical coherence tomography (OCT) retinal scans is necessary for disease monitoring, prognostic research, and clinical endpoints for therapy development. Such automatically quantified biomarkers on OCT are likely to further elucidate structure-function correlation in GA and thus the pathophysiological mechanisms of disease development and progression. In this work, we aimed to predict visual function with machine-learning applied to automatically acquired quantitative imaging biomarkers in GA. A post-hoc analysis of data from a clinical trial and routine clinical care was conducted. A deep-learning automated segmentation model was applied on OCT scans from 476 eyes (325 patients) with GA. A separate machine learning prediction model (Random Forest) used the resultant quantitative OCT (qOCT) biomarkers to predict cross-sectional visual acuity under standard (VA) and low luminance (LLVA). The primary outcome was regression coefficient (r

Identifiants

pubmed: 36114218
doi: 10.1038/s41598-022-19413-z
pii: 10.1038/s41598-022-19413-z
pmc: PMC9481631
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

15565

Subventions

Organisme : Medical Research Council
ID : MR/T019050/1
Pays : United Kingdom

Informations de copyright

© 2022. The Author(s).

Références

Korean J Ophthalmol. 2021 Dec;35(6):448-454
pubmed: 34488258
Ophthalmol Retina. 2020 Jul;4(7):673-688
pubmed: 32199866
Retina. 2021 Jan 1;41(1):144-155
pubmed: 32134802
J Vis Impair Blind. 2008 Nov;102(11):679-689
pubmed: 20585406
Clin Ophthalmol. 2020 Jun 04;14:1533-1545
pubmed: 32669830
Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1782-9
pubmed: 27074381
Ophthalmology. 2018 Dec;125(12):1913-1928
pubmed: 30060980
Ophthalmology. 2020 Aug;127(8):1086-1096
pubmed: 32197912
Br J Ophthalmol. 2021 Nov;105(11):1469-1474
pubmed: 32950958
Optom Vis Sci. 2000 Aug;77(8):412-20
pubmed: 10966067
Ophthalmology. 2020 Mar;127(3):394-409
pubmed: 31708275
Ophthalmol Retina. 2021 Nov;5(11):1074-1084
pubmed: 33516917
Ophthalmology. 2018 Apr;125(4):537-548
pubmed: 29103793
Ophthalmologica. 2011;226(4):182-90
pubmed: 21865677
JAMA Ophthalmol. 2015 Apr;133(4):442-8
pubmed: 25632841
Ophthalmic Physiol Opt. 2021 Mar;41(2):213-223
pubmed: 33403668
Am J Ophthalmol. 2016 Aug;168:1-12
pubmed: 27131774
Am J Ophthalmol. 2017 Jul;179:118-128
pubmed: 28385474
JAMA Ophthalmol. 2014 Mar;132(3):338-45
pubmed: 24626824
Clin Ophthalmol. 2015 Nov 20;9:2159-74
pubmed: 26640366
Ophthalmic Physiol Opt. 2006 May;26(3):225-39
pubmed: 16684149
Ophthalmology. 2020 Feb;127(2):186-195
pubmed: 31474439
Graefes Arch Clin Exp Ophthalmol. 2018 Sep;256(9):1739-1746
pubmed: 29808376
Ophthalmol Retina. 2018 Jan;2(1):24-30
pubmed: 31047298
Front Psychol. 2015 Jan 22;5:1594
pubmed: 25657632
Am J Ophthalmol. 2021 Jun;226:1-12
pubmed: 33422464
Br J Ophthalmol. 2016 Mar;100(3):395-8
pubmed: 26250520
J Vitreoretin Dis. 2019 Sep;3(5):278-282
pubmed: 31723722
Retina. 2016 Dec;36(12):2250-2264
pubmed: 27552292
Mutagenesis. 2012 Jan;27(1):17-29
pubmed: 22027842
Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4347-52
pubmed: 18566455
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3456-3463
pubmed: 28702674
Ophthalmology. 2017 Apr;124(4):464-478
pubmed: 28109563
Lancet Digit Health. 2021 Oct;3(10):e665-e675
pubmed: 34509423
Arch Ophthalmol. 1973 Sep;90(3):206-17
pubmed: 4738143
Ophthalmology. 2008 Sep;115(9):1480-8, 1488.e1-2
pubmed: 18486216
Acta Ophthalmol Scand. 1999 Dec;77(6):673-6
pubmed: 10634561
Am J Ophthalmol. 2020 Sep;217:162-173
pubmed: 32289293
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIO61-BIO67
pubmed: 28475704

Auteurs

Konstantinos Balaskas (K)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK. k.balaskas@nhs.net.

S Glinton (S)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

T D L Keenan (TDL)

Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.

L Faes (L)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

B Liefers (B)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.
Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, The Netherlands.

G Zhang (G)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

N Pontikos (N)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

R Struyven (R)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

S K Wagner (SK)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

A McKeown (A)

Apellis Pharmaceuticals, Inc, Waltham, MA, USA.

P J Patel (PJ)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

P A Keane (PA)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

D J Fu (DJ)

NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, Moorfields Reading Centre and Clinical AI Hub, 162 City Rd, London, EC1V 2PD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH